123 related articles for article (PubMed ID: 38245863)
21. Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance.
Lin X; Zhang Q; Li Q; Deng J; Shen S; Tang M; Ye X; Ji C; Yang Y; Chen Y; Zeng L; Zhao J; Kouwenhoven MBN; Lucero-Prisno DE; Huang J; Li Y; Zhang B; Hu J
Drug Resist Updat; 2024 Mar; 73():101032. PubMed ID: 38198846
[TBL] [Abstract][Full Text] [Related]
22. Monitoring ROS Responsive Fe
Zhang L; Qiu M; Wang R; Li S; Liu X; Xu Q; Xiao L; Jiang ZX; Zhou X; Chen S
Angew Chem Int Ed Engl; 2024 May; 63(22):e202403771. PubMed ID: 38551448
[TBL] [Abstract][Full Text] [Related]
23. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
24. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional Tumor-Targeting Carbon Dots for Tumor Microenvironment Activated Ferroptosis and Immunotherapy in Cancer Treatment.
Bao Y; Li G; Li S; Zhang H; Wu X; Yan R; Wang Z; Guo C; Jin Y
ACS Appl Mater Interfaces; 2023 Nov; ():. PubMed ID: 38015563
[TBL] [Abstract][Full Text] [Related]
26. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
27. Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy.
Liu Y; Jiang M; Zhao Z; Wang N; Wang K; Yuan Y
Acta Biomater; 2023 Aug; 166():567-580. PubMed ID: 37207741
[TBL] [Abstract][Full Text] [Related]
28. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
[TBL] [Abstract][Full Text] [Related]
29. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
[TBL] [Abstract][Full Text] [Related]
30. Photo-Enhanced Synergistic Induction of Ferroptosis for Anti-Cancer Immunotherapy.
Zhou Y; Chen K; Lin WK; Liu J; Kang W; Zhang Y; Yang R; Jin L; Cheng Y; Xu A; Wang W
Adv Healthc Mater; 2023 Oct; 12(27):e2300994. PubMed ID: 37432874
[TBL] [Abstract][Full Text] [Related]
31. A glutathione-responsive sulfur dioxide polymer prodrug selectively induces ferroptosis in gastric cancer therapy.
Xia M; Guo Z; Liu X; Wang Y; Xiao C
Biomater Sci; 2022 Jul; 10(15):4184-4192. PubMed ID: 35727040
[TBL] [Abstract][Full Text] [Related]
32. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-γ-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors.
Tao Q; Liu N; Wu J; Chen J; Chen X; Peng C
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471712
[TBL] [Abstract][Full Text] [Related]
33. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
[TBL] [Abstract][Full Text] [Related]
34. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation.
Zhou C; Yu T; Zhu R; Lu J; Ouyang X; Zhang Z; Chen Q; Li J; Cui J; Jiang F; Jin KY; Sarapultsev A; Li F; Zhang G; Luo S; Hu D
Int J Biol Sci; 2023; 19(5):1471-1489. PubMed ID: 37056925
[TBL] [Abstract][Full Text] [Related]
35. Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer.
Li X; Niu J; Deng L; Yu Y; Zhang L; Chen Q; Zhao J; Wang B; Gao H
Acta Biomater; 2024 Jan; 173():432-441. PubMed ID: 37984629
[TBL] [Abstract][Full Text] [Related]
36. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
37. Delivery of a system x
Xin H; Huang Y; Tang H; Chen Y; Xia H; Zhang F; Li B; Ping Y
J Mater Chem B; 2021 Sep; 9(35):7172-7181. PubMed ID: 34369535
[TBL] [Abstract][Full Text] [Related]
38. Cyclodextrin-Derived ROS-Generating Nanomedicine with pH-Modulated Degradability to Enhance Tumor Ferroptosis Therapy and Chemotherapy.
Xu M; Zha H; Han R; Cheng Y; Chen J; Yue L; Wang R; Zheng Y
Small; 2022 May; 18(20):e2200330. PubMed ID: 35451223
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating ferroptosis.
Sun Y; He Y; Tong J; Liu D; Zhang H; He T; Bi Y
Genes Dis; 2022 Nov; 9(6):1742-1756. PubMed ID: 36157492
[TBL] [Abstract][Full Text] [Related]
40. An Activatable Prodrug Nanosystem for Ultrasound-Driven Multimodal Tumor Therapy and Metastasis Inhibition.
Zheng J; Ge H; Zhou D; Yao Q; Long S; Sun W; Fan J; Du J; Peng X
Adv Mater; 2023 Nov; 35(47):e2308205. PubMed ID: 37792315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
